Therapeutic Areas: Hematology | Family Medicine

Anemia Clinical Trials

A listing of Anemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Alhambra California 91801

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Irvine California 92604

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Los Angeles California 91326

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Pasadena California 91105

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Torrance California 90505

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Valencia California 91355

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Ventura California 93003

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

UPDATED

Westlake Village California 91361

Patients are needed to participate in a clinical research study of FG-4592 and Placebo to evaluate Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Hong Kong

UPDATED

Hong Kong

A clinical trial seeking patients for a research study for the treatment of Severe Aplastic Anemia

Israel

UPDATED

Afula 1834111

Patients are needed to participate in a clinical research study of Ilaris, Canakinumab and Placebo to evaluate Sickle Cell Anemia

Italy

UPDATED

Brescia BR 25123

A clinical trial seeking patients for a research study for the treatment of Severe Aplastic Anemia

UPDATED

Milano MI 20122

A clinical trial seeking patients for a research study for the treatment of Severe Aplastic Anemia

Japan

UPDATED

Aichi

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Aichi

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Aichi

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Aichi

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Aichi

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Aichi

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Aichi

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Aichi

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Chiba

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Chiba

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Ehime

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Ehime

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Ehime

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Ehime

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Ehime

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukui

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukui

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Fukui

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukui

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A clinical trial to evaluate treatments using ASP1517 and DA for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Fukuoka

A Phase 3 clinical study for patients with Chronic Kidney Disease

UPDATED

Fukuoka

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukuoka

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukushima

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia

UPDATED

Fukushima

Patients are needed to participate in a clinical research study of ASP1517 and Darbepoetine alfa to evaluate Hemodialysis Chronic Kidney Disease Patients With Anemia